Literature DB >> 16287607

Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.

Arne Kroidl1, A Schaeben, M Oette, M Wettstein, A Herfordt, D Häussinger.   

Abstract

A cross-sectional study examining oral manifestations was carried out in HIV-infected patients of a general HIV-specialized unit to provide prevalence data on oral lesions and periodontal diseases. The occurrence of oral lesions was correlated with demographic and clinical characteristics, immunologic and virologic parameters. Among 139 patients 86% presented any oral lesions with a prevalence of 76% of any periodontal diseases. Most periodontal lesions were classified as conventional gingivitis (28%) or periodontitis (30%). Dental plaque formation was associated with a higher prevalence of periodontal diseases (p = 0.01) and periodontal inflammation scores were higher in patients with more reduced CD4-counts (p = 0.03). Prevalence for HIV-specific oral lesions was 29% with a proportion of 9% of linear gingival erythema (LGE), 3.6% of necrotizing and ulcerative gingivitis (NUG) or periodontitis (NUP), 7% of oral candidiasis, 3.6% of oral hairy leucoplakia (OHL) and single other lesions. HIV-specific lesions (NUG/NUP, oral candidiasis and OHL) were found predominantly in patients with advanced immunosuppression and elevated viral load. Compared with data of oral diseases of the pre-HAART era prevalence of HIV-specific lesions was markedly reduced. Especially frequently known lesions such as oral candidiasis and OHL were less common seen. We noticed a shift of prevalence towards periodontal diseases. Lack of oral hygiene determined by plaque formation and reduced CD4-counts with pronounced periodontal inflammation can be seen as risk factors for periodontal disease. Overall high prevalence of manifestations underlines the importance of oral examination for the general practitioner and visits by oral specialists should become a routine procedure in HIV-patients care.

Entities:  

Mesh:

Year:  2005        PMID: 16287607

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  11 in total

Review 1.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

2.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

3.  Suppression of transforming growth factor β receptor 2 and Smad5 is associated with high levels of microRNA miR-155 in the oral mucosa during chronic simian immunodeficiency virus infection.

Authors:  Jeffy George; Mark G Lewis; Rolf Renne; Joseph J Mattapallil
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

4.  Periodontal Disease Status and Associated Risk Factors in Patients Attending a Tertiary Hospital in Northwest Ethiopia.

Authors:  Amare Tefera; Biruk Bekele
Journal:  Clin Cosmet Investig Dent       Date:  2020-11-10

5.  Prevalence of oromucosal lesions in HIV positive patients receiving haart-A prospective clinical study.

Authors:  Saritha Maloth; T R Shrinivas; B Krishna Pramod; P J Nagarathna
Journal:  J Family Med Prim Care       Date:  2020-09-30

6.  Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study.

Authors:  Ulrich Fricke; Werner Geurtsen; Ingmar Staufenbiel; Alexander Rahman
Journal:  Eur J Med Res       Date:  2012-01-30       Impact factor: 2.175

7.  Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur.

Authors:  Jagganatha Rao Ravi; Tuthipat Ramachandra Gururaja Rao
Journal:  J Indian Soc Periodontol       Date:  2015 Jul-Aug

8.  The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India.

Authors:  Neelkant Patil; Vishwajit Rampratap Chaurasia; Prashant Babaji; Dnsv Ramesh; Kshitij Jhamb; Akanksha Manmohan Sharma
Journal:  Eur J Dent       Date:  2015 Jan-Mar

9.  Candida spp. Determination and Th1/Th2 Mixed Cytokine Profile in Oral Samples From HIV+ Patients With Chronic Periodontitis.

Authors:  Sarah M Lomeli-Martinez; Eulogio Valentin-Goméz; Juan J Varela-Hernández; Monserrat Alvarez-Zavala; Karina Sanchez-Reyes; Moises Ramos-Solano; Rodolfo I Cabrera-Silva; Victor M Ramirez-Anguiano; Manuel A Lomeli-Martinez; Silvia Y Martinez-Salazar; Luz A González-Hernández; Jaime F Andrade-Villanueva
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

10.  First evidence of genetic intraspecific variability and occurrence of Entamoeba gingivalis in HIV(+)/AIDS.

Authors:  Sibeli B S Cembranelli; Fernanda O Souto; Kennio Ferreira-Paim; Túlio T Richinho; Poliana L Nunes; Gabriel A N Nascentes; Thatiana B Ferreira; Dalmo Correia; Eliane Lages-Silva
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.